Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 14,533 | 3,288 | 3,428 | 0 | 950 |
| Gross Profit | 14,533 | 3,288 | 3,428 | N/A | 950 |
| Operating Expenses | 22,616 | 17,480 | 14,675 | 0 | 12,811 |
| Operating Income | -8,083 | -14,192 | -11,247 | N/A | -11,861 |
| Interest Expense | 28 | 25 | 34 | 0 | 4 |
| Other Income | 125 | 228 | 349 | 0 | 445 |
| Pre-tax Income | -7,986 | -13,989 | -10,932 | 0 | -11,420 |
| Net Income Continuous | -7,986 | -13,989 | -10,932 | N/A | -11,420 |
| Net Income | $-7,986 | $-13,989 | $-10,932 | $N/A | $-11,420 |
| EPS Basic Total Ops | -0.39 | -6.98 | -10.23 | N/A | -6.54 |
| EPS Basic Continuous Ops | -0.39 | -6.98 | -5.60 | N/A | -6.54 |
| EPS Diluted Total Ops | -0.39 | -6.98 | -10.23 | N/A | -6.54 |
| EPS Diluted Continuous Ops | -0.39 | -6.98 | -5.60 | N/A | -6.54 |
| EBITDA(a) | $-7,593 | $-13,803 | $-10,860 | $N/A | $-11,861 |